Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene

Highly specialised technologies guidance
Reference number: HST3
Published: 20 July 2016

Tools and resources

Education

Contract variation agreement No 1 to managed access agreement (PDF 199 KB)

Published:

13 August 2021
Addendum to Managed Access Agreement (PDF 268 KB)

Published:

01 May 2019
Managed access agreement – July 2016 (PDF 208 KB)

Published:

20 July 2016

Guidance into practice